SC Medicaid program to stop covering expensive weight loss drugs for obesity South Carolina was among 14 states that offered the medication for obesity as well as diabetes South Carolina will stop covering GLP-1 drugs such as Wegovy for weight loss on Jan
These symptoms can indicate hypoglycaemia, particularly in individuals taking Ozempic in combination with insulin or sulfonylureas
These properties establish cyclodextrins as crucial components in the treatment of ocular diseases, playing a vital role that cannot be overlooked
These symptoms may indicate thyroid dysfunction, anemia, or other conditions requiring evaluation and treatment
Last updated: June 19, 2026.
Ongoing access to clinical support for questions, side effect management, and dose adjustments